The risk of mycobacterial infections associated with inhaled corticosteroid use

Sarah K. Brode, Michael A. Campitelli, Jeffrey C. Kwong, Hong Lu, Alex Marchand-Austin, Andrea S. Gershon, Frances B. Jamieson, Theodore K. Marras

Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sarah K. Brode, Michael A. Campitelli, Jeffrey C. Kwong, Hong Lu, Alex Marchand-Austin, Andrea S. Gershon, Frances B. Jamieson, Theodore K. Marras. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled corticosteroids and the increased risk of non-tuberculous mycobacteria infection
Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection
Year: 2019


Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007


Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


High prevalence of yeasts and mycosis infections in a COPD population after long term use of inhaled steroid
Source: Eur Respir J 2005; 26: Suppl. 49, 407s
Year: 2005

Incidence of oropharyngeal candidiasis during treatment with high doses of inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Source: Eur Respir J, 50 (4) 1700451; 10.1183/13993003.00451-2017
Year: 2017



Inhaled drugs as risk factors for community-acquired pneumonia
Source: Eur Respir J 2010; 36: 1080-1087
Year: 2010



Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Influence of inhaled bronchodilator therapy on bacterioexcretion and LQ in patients with pulmonary TB infection with concomitant broncho-obstructive syndrome
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Source: Eur Respir J 2010; 36: 751-757
Year: 2010



Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?
Source: Eur Respir J 2011; 37: 1-3
Year: 2011


Inhaled drugs as risk factors for community-acquired pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010


Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
Source: Eur Respir J 2009; 34: 641
Year: 2009



Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018
Year: 2019



Effect of different asthma treatments on risk of cold-related exacerbations
Source: Eur Respir J 2011; 38: 584-593
Year: 2011



Estimation of risk of osteoporosis based on inhaled and oral corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002